Global CD55 Antibody Supply, Demand and Key Producers, 2023-2029
The global CD55 Antibody market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
This report studies the global CD55 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD55 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD55 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD55 Antibody total market, 2018-2029, (USD Million)
Global CD55 Antibody total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CD55 Antibody total market, key domestic companies and share, (USD Million)
Global CD55 Antibody revenue by player and market share 2018-2023, (USD Million)
Global CD55 Antibody total market by Type, CAGR, 2018-2029, (USD Million)
Global CD55 Antibody total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global CD55 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, Leading Biology, ProSci and Bethyl Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD55 Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD55 Antibody Market, By Region:
1. How big is the global CD55 Antibody market?
2. What is the demand of the global CD55 Antibody market?
3. What is the year over year growth of the global CD55 Antibody market?
4. What is the total value of the global CD55 Antibody market?
5. Who are the major players in the global CD55 Antibody market?
6. What are the growth factors driving the market demand?
CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
This report studies the global CD55 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD55 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD55 Antibody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD55 Antibody total market, 2018-2029, (USD Million)
Global CD55 Antibody total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CD55 Antibody total market, key domestic companies and share, (USD Million)
Global CD55 Antibody revenue by player and market share 2018-2023, (USD Million)
Global CD55 Antibody total market by Type, CAGR, 2018-2029, (USD Million)
Global CD55 Antibody total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global CD55 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, Leading Biology, ProSci and Bethyl Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD55 Antibody market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD55 Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal
- Polyclonal
- Immunochemistry (IHC)
- Immunofluorescence (IF)
- Immunoprecipitation (IP)
- Western Blot (WB)
- ELISA
- Others
- Merck
- Thermo Fisher Scientific
- Proteintech Group
- Aviva Systems Biology
- LifeSpan BioSciences
- RayBiotech
- Leading Biology
- ProSci
- Bethyl Laboratories
- OriGene Technologies
- Novus Biologicals
- Cell Signaling Technology
- Abcam
- GeneTex
- United States Biological
- St John's Laboratory
- Creative Diagnostics
- Biobyt
- Jingjie PTM BioLab
1. How big is the global CD55 Antibody market?
2. What is the demand of the global CD55 Antibody market?
3. What is the year over year growth of the global CD55 Antibody market?
4. What is the total value of the global CD55 Antibody market?
5. Who are the major players in the global CD55 Antibody market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CD55 Antibody Introduction
1.2 World CD55 Antibody Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CD55 Antibody Total Market by Region (by Headquarter Location)
1.3.1 World CD55 Antibody Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CD55 Antibody Market Size (2018-2029)
1.3.3 China CD55 Antibody Market Size (2018-2029)
1.3.4 Europe CD55 Antibody Market Size (2018-2029)
1.3.5 Japan CD55 Antibody Market Size (2018-2029)
1.3.6 South Korea CD55 Antibody Market Size (2018-2029)
1.3.7 ASEAN CD55 Antibody Market Size (2018-2029)
1.3.8 India CD55 Antibody Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD55 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD55 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD55 Antibody Consumption Value (2018-2029)
2.2 World CD55 Antibody Consumption Value by Region
2.2.1 World CD55 Antibody Consumption Value by Region (2018-2023)
2.2.2 World CD55 Antibody Consumption Value Forecast by Region (2024-2029)
2.3 United States CD55 Antibody Consumption Value (2018-2029)
2.4 China CD55 Antibody Consumption Value (2018-2029)
2.5 Europe CD55 Antibody Consumption Value (2018-2029)
2.6 Japan CD55 Antibody Consumption Value (2018-2029)
2.7 South Korea CD55 Antibody Consumption Value (2018-2029)
2.8 ASEAN CD55 Antibody Consumption Value (2018-2029)
2.9 India CD55 Antibody Consumption Value (2018-2029)
3 WORLD CD55 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
3.1 World CD55 Antibody Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CD55 Antibody Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CD55 Antibody in 2022
3.2.3 Global Concentration Ratios (CR8) for CD55 Antibody in 2022
3.3 CD55 Antibody Company Evaluation Quadrant
3.4 CD55 Antibody Market: Overall Company Footprint Analysis
3.4.1 CD55 Antibody Market: Region Footprint
3.4.2 CD55 Antibody Market: Company Product Type Footprint
3.4.3 CD55 Antibody Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CD55 Antibody Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CD55 Antibody Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CD55 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CD55 Antibody Consumption Value Comparison
4.2.1 United States VS China: CD55 Antibody Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD55 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CD55 Antibody Companies and Market Share, 2018-2023
4.3.1 United States Based CD55 Antibody Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CD55 Antibody Revenue, (2018-2023)
4.4 China Based Companies CD55 Antibody Revenue and Market Share, 2018-2023
4.4.1 China Based CD55 Antibody Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CD55 Antibody Revenue, (2018-2023)
4.5 Rest of World Based CD55 Antibody Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CD55 Antibody Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CD55 Antibody Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD55 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Segment by Type
5.3.1 World CD55 Antibody Market Size by Type (2018-2023)
5.3.2 World CD55 Antibody Market Size by Type (2024-2029)
5.3.3 World CD55 Antibody Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD55 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immunochemistry (IHC)
6.2.2 Immunofluorescence (IF)
6.2.3 Immunoprecipitation (IP)
6.2.4 Western Blot (WB)
6.2.5 Western Blot (WB)
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World CD55 Antibody Market Size by Application (2018-2023)
6.3.2 World CD55 Antibody Market Size by Application (2024-2029)
6.3.3 World CD55 Antibody Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck CD55 Antibody Product and Services
7.1.4 Merck CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific CD55 Antibody Product and Services
7.2.4 Thermo Fisher Scientific CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Proteintech Group
7.3.1 Proteintech Group Details
7.3.2 Proteintech Group Major Business
7.3.3 Proteintech Group CD55 Antibody Product and Services
7.3.4 Proteintech Group CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Proteintech Group Recent Developments/Updates
7.3.6 Proteintech Group Competitive Strengths & Weaknesses
7.4 Aviva Systems Biology
7.4.1 Aviva Systems Biology Details
7.4.2 Aviva Systems Biology Major Business
7.4.3 Aviva Systems Biology CD55 Antibody Product and Services
7.4.4 Aviva Systems Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Aviva Systems Biology Recent Developments/Updates
7.4.6 Aviva Systems Biology Competitive Strengths & Weaknesses
7.5 LifeSpan BioSciences
7.5.1 LifeSpan BioSciences Details
7.5.2 LifeSpan BioSciences Major Business
7.5.3 LifeSpan BioSciences CD55 Antibody Product and Services
7.5.4 LifeSpan BioSciences CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 LifeSpan BioSciences Recent Developments/Updates
7.5.6 LifeSpan BioSciences Competitive Strengths & Weaknesses
7.6 RayBiotech
7.6.1 RayBiotech Details
7.6.2 RayBiotech Major Business
7.6.3 RayBiotech CD55 Antibody Product and Services
7.6.4 RayBiotech CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 RayBiotech Recent Developments/Updates
7.6.6 RayBiotech Competitive Strengths & Weaknesses
7.7 Leading Biology
7.7.1 Leading Biology Details
7.7.2 Leading Biology Major Business
7.7.3 Leading Biology CD55 Antibody Product and Services
7.7.4 Leading Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Leading Biology Recent Developments/Updates
7.7.6 Leading Biology Competitive Strengths & Weaknesses
7.8 ProSci
7.8.1 ProSci Details
7.8.2 ProSci Major Business
7.8.3 ProSci CD55 Antibody Product and Services
7.8.4 ProSci CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 ProSci Recent Developments/Updates
7.8.6 ProSci Competitive Strengths & Weaknesses
7.9 Bethyl Laboratories
7.9.1 Bethyl Laboratories Details
7.9.2 Bethyl Laboratories Major Business
7.9.3 Bethyl Laboratories CD55 Antibody Product and Services
7.9.4 Bethyl Laboratories CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bethyl Laboratories Recent Developments/Updates
7.9.6 Bethyl Laboratories Competitive Strengths & Weaknesses
7.10 OriGene Technologies
7.10.1 OriGene Technologies Details
7.10.2 OriGene Technologies Major Business
7.10.3 OriGene Technologies CD55 Antibody Product and Services
7.10.4 OriGene Technologies CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 OriGene Technologies Recent Developments/Updates
7.10.6 OriGene Technologies Competitive Strengths & Weaknesses
7.11 Novus Biologicals
7.11.1 Novus Biologicals Details
7.11.2 Novus Biologicals Major Business
7.11.3 Novus Biologicals CD55 Antibody Product and Services
7.11.4 Novus Biologicals CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Novus Biologicals Recent Developments/Updates
7.11.6 Novus Biologicals Competitive Strengths & Weaknesses
7.12 Cell Signaling Technology
7.12.1 Cell Signaling Technology Details
7.12.2 Cell Signaling Technology Major Business
7.12.3 Cell Signaling Technology CD55 Antibody Product and Services
7.12.4 Cell Signaling Technology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cell Signaling Technology Recent Developments/Updates
7.12.6 Cell Signaling Technology Competitive Strengths & Weaknesses
7.13 Abcam
7.13.1 Abcam Details
7.13.2 Abcam Major Business
7.13.3 Abcam CD55 Antibody Product and Services
7.13.4 Abcam CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Abcam Recent Developments/Updates
7.13.6 Abcam Competitive Strengths & Weaknesses
7.14 GeneTex
7.14.1 GeneTex Details
7.14.2 GeneTex Major Business
7.14.3 GeneTex CD55 Antibody Product and Services
7.14.4 GeneTex CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 GeneTex Recent Developments/Updates
7.14.6 GeneTex Competitive Strengths & Weaknesses
7.15 United States Biological
7.15.1 United States Biological Details
7.15.2 United States Biological Major Business
7.15.3 United States Biological CD55 Antibody Product and Services
7.15.4 United States Biological CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 United States Biological Recent Developments/Updates
7.15.6 United States Biological Competitive Strengths & Weaknesses
7.16 St John's Laboratory
7.16.1 St John's Laboratory Details
7.16.2 St John's Laboratory Major Business
7.16.3 St John's Laboratory CD55 Antibody Product and Services
7.16.4 St John's Laboratory CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 St John's Laboratory Recent Developments/Updates
7.16.6 St John's Laboratory Competitive Strengths & Weaknesses
7.17 Creative Diagnostics
7.17.1 Creative Diagnostics Details
7.17.2 Creative Diagnostics Major Business
7.17.3 Creative Diagnostics CD55 Antibody Product and Services
7.17.4 Creative Diagnostics CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Creative Diagnostics Recent Developments/Updates
7.17.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.18 Biobyt
7.18.1 Biobyt Details
7.18.2 Biobyt Major Business
7.18.3 Biobyt CD55 Antibody Product and Services
7.18.4 Biobyt CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Biobyt Recent Developments/Updates
7.18.6 Biobyt Competitive Strengths & Weaknesses
7.19 Jingjie PTM BioLab
7.19.1 Jingjie PTM BioLab Details
7.19.2 Jingjie PTM BioLab Major Business
7.19.3 Jingjie PTM BioLab CD55 Antibody Product and Services
7.19.4 Jingjie PTM BioLab CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Jingjie PTM BioLab Recent Developments/Updates
7.19.6 Jingjie PTM BioLab Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD55 Antibody Industry Chain
8.2 CD55 Antibody Upstream Analysis
8.3 CD55 Antibody Midstream Analysis
8.4 CD55 Antibody Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CD55 Antibody Introduction
1.2 World CD55 Antibody Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CD55 Antibody Total Market by Region (by Headquarter Location)
1.3.1 World CD55 Antibody Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CD55 Antibody Market Size (2018-2029)
1.3.3 China CD55 Antibody Market Size (2018-2029)
1.3.4 Europe CD55 Antibody Market Size (2018-2029)
1.3.5 Japan CD55 Antibody Market Size (2018-2029)
1.3.6 South Korea CD55 Antibody Market Size (2018-2029)
1.3.7 ASEAN CD55 Antibody Market Size (2018-2029)
1.3.8 India CD55 Antibody Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD55 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD55 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD55 Antibody Consumption Value (2018-2029)
2.2 World CD55 Antibody Consumption Value by Region
2.2.1 World CD55 Antibody Consumption Value by Region (2018-2023)
2.2.2 World CD55 Antibody Consumption Value Forecast by Region (2024-2029)
2.3 United States CD55 Antibody Consumption Value (2018-2029)
2.4 China CD55 Antibody Consumption Value (2018-2029)
2.5 Europe CD55 Antibody Consumption Value (2018-2029)
2.6 Japan CD55 Antibody Consumption Value (2018-2029)
2.7 South Korea CD55 Antibody Consumption Value (2018-2029)
2.8 ASEAN CD55 Antibody Consumption Value (2018-2029)
2.9 India CD55 Antibody Consumption Value (2018-2029)
3 WORLD CD55 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
3.1 World CD55 Antibody Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CD55 Antibody Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CD55 Antibody in 2022
3.2.3 Global Concentration Ratios (CR8) for CD55 Antibody in 2022
3.3 CD55 Antibody Company Evaluation Quadrant
3.4 CD55 Antibody Market: Overall Company Footprint Analysis
3.4.1 CD55 Antibody Market: Region Footprint
3.4.2 CD55 Antibody Market: Company Product Type Footprint
3.4.3 CD55 Antibody Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CD55 Antibody Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CD55 Antibody Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CD55 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CD55 Antibody Consumption Value Comparison
4.2.1 United States VS China: CD55 Antibody Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD55 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CD55 Antibody Companies and Market Share, 2018-2023
4.3.1 United States Based CD55 Antibody Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CD55 Antibody Revenue, (2018-2023)
4.4 China Based Companies CD55 Antibody Revenue and Market Share, 2018-2023
4.4.1 China Based CD55 Antibody Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CD55 Antibody Revenue, (2018-2023)
4.5 Rest of World Based CD55 Antibody Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CD55 Antibody Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CD55 Antibody Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD55 Antibody Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal
5.2.2 Polyclonal
5.3 Market Segment by Type
5.3.1 World CD55 Antibody Market Size by Type (2018-2023)
5.3.2 World CD55 Antibody Market Size by Type (2024-2029)
5.3.3 World CD55 Antibody Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD55 Antibody Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immunochemistry (IHC)
6.2.2 Immunofluorescence (IF)
6.2.3 Immunoprecipitation (IP)
6.2.4 Western Blot (WB)
6.2.5 Western Blot (WB)
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World CD55 Antibody Market Size by Application (2018-2023)
6.3.2 World CD55 Antibody Market Size by Application (2024-2029)
6.3.3 World CD55 Antibody Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck CD55 Antibody Product and Services
7.1.4 Merck CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific CD55 Antibody Product and Services
7.2.4 Thermo Fisher Scientific CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Proteintech Group
7.3.1 Proteintech Group Details
7.3.2 Proteintech Group Major Business
7.3.3 Proteintech Group CD55 Antibody Product and Services
7.3.4 Proteintech Group CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Proteintech Group Recent Developments/Updates
7.3.6 Proteintech Group Competitive Strengths & Weaknesses
7.4 Aviva Systems Biology
7.4.1 Aviva Systems Biology Details
7.4.2 Aviva Systems Biology Major Business
7.4.3 Aviva Systems Biology CD55 Antibody Product and Services
7.4.4 Aviva Systems Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Aviva Systems Biology Recent Developments/Updates
7.4.6 Aviva Systems Biology Competitive Strengths & Weaknesses
7.5 LifeSpan BioSciences
7.5.1 LifeSpan BioSciences Details
7.5.2 LifeSpan BioSciences Major Business
7.5.3 LifeSpan BioSciences CD55 Antibody Product and Services
7.5.4 LifeSpan BioSciences CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 LifeSpan BioSciences Recent Developments/Updates
7.5.6 LifeSpan BioSciences Competitive Strengths & Weaknesses
7.6 RayBiotech
7.6.1 RayBiotech Details
7.6.2 RayBiotech Major Business
7.6.3 RayBiotech CD55 Antibody Product and Services
7.6.4 RayBiotech CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 RayBiotech Recent Developments/Updates
7.6.6 RayBiotech Competitive Strengths & Weaknesses
7.7 Leading Biology
7.7.1 Leading Biology Details
7.7.2 Leading Biology Major Business
7.7.3 Leading Biology CD55 Antibody Product and Services
7.7.4 Leading Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Leading Biology Recent Developments/Updates
7.7.6 Leading Biology Competitive Strengths & Weaknesses
7.8 ProSci
7.8.1 ProSci Details
7.8.2 ProSci Major Business
7.8.3 ProSci CD55 Antibody Product and Services
7.8.4 ProSci CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 ProSci Recent Developments/Updates
7.8.6 ProSci Competitive Strengths & Weaknesses
7.9 Bethyl Laboratories
7.9.1 Bethyl Laboratories Details
7.9.2 Bethyl Laboratories Major Business
7.9.3 Bethyl Laboratories CD55 Antibody Product and Services
7.9.4 Bethyl Laboratories CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bethyl Laboratories Recent Developments/Updates
7.9.6 Bethyl Laboratories Competitive Strengths & Weaknesses
7.10 OriGene Technologies
7.10.1 OriGene Technologies Details
7.10.2 OriGene Technologies Major Business
7.10.3 OriGene Technologies CD55 Antibody Product and Services
7.10.4 OriGene Technologies CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 OriGene Technologies Recent Developments/Updates
7.10.6 OriGene Technologies Competitive Strengths & Weaknesses
7.11 Novus Biologicals
7.11.1 Novus Biologicals Details
7.11.2 Novus Biologicals Major Business
7.11.3 Novus Biologicals CD55 Antibody Product and Services
7.11.4 Novus Biologicals CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Novus Biologicals Recent Developments/Updates
7.11.6 Novus Biologicals Competitive Strengths & Weaknesses
7.12 Cell Signaling Technology
7.12.1 Cell Signaling Technology Details
7.12.2 Cell Signaling Technology Major Business
7.12.3 Cell Signaling Technology CD55 Antibody Product and Services
7.12.4 Cell Signaling Technology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cell Signaling Technology Recent Developments/Updates
7.12.6 Cell Signaling Technology Competitive Strengths & Weaknesses
7.13 Abcam
7.13.1 Abcam Details
7.13.2 Abcam Major Business
7.13.3 Abcam CD55 Antibody Product and Services
7.13.4 Abcam CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Abcam Recent Developments/Updates
7.13.6 Abcam Competitive Strengths & Weaknesses
7.14 GeneTex
7.14.1 GeneTex Details
7.14.2 GeneTex Major Business
7.14.3 GeneTex CD55 Antibody Product and Services
7.14.4 GeneTex CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 GeneTex Recent Developments/Updates
7.14.6 GeneTex Competitive Strengths & Weaknesses
7.15 United States Biological
7.15.1 United States Biological Details
7.15.2 United States Biological Major Business
7.15.3 United States Biological CD55 Antibody Product and Services
7.15.4 United States Biological CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 United States Biological Recent Developments/Updates
7.15.6 United States Biological Competitive Strengths & Weaknesses
7.16 St John's Laboratory
7.16.1 St John's Laboratory Details
7.16.2 St John's Laboratory Major Business
7.16.3 St John's Laboratory CD55 Antibody Product and Services
7.16.4 St John's Laboratory CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 St John's Laboratory Recent Developments/Updates
7.16.6 St John's Laboratory Competitive Strengths & Weaknesses
7.17 Creative Diagnostics
7.17.1 Creative Diagnostics Details
7.17.2 Creative Diagnostics Major Business
7.17.3 Creative Diagnostics CD55 Antibody Product and Services
7.17.4 Creative Diagnostics CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Creative Diagnostics Recent Developments/Updates
7.17.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.18 Biobyt
7.18.1 Biobyt Details
7.18.2 Biobyt Major Business
7.18.3 Biobyt CD55 Antibody Product and Services
7.18.4 Biobyt CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Biobyt Recent Developments/Updates
7.18.6 Biobyt Competitive Strengths & Weaknesses
7.19 Jingjie PTM BioLab
7.19.1 Jingjie PTM BioLab Details
7.19.2 Jingjie PTM BioLab Major Business
7.19.3 Jingjie PTM BioLab CD55 Antibody Product and Services
7.19.4 Jingjie PTM BioLab CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Jingjie PTM BioLab Recent Developments/Updates
7.19.6 Jingjie PTM BioLab Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD55 Antibody Industry Chain
8.2 CD55 Antibody Upstream Analysis
8.3 CD55 Antibody Midstream Analysis
8.4 CD55 Antibody Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CD55 Antibody Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CD55 Antibody Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CD55 Antibody Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CD55 Antibody Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CD55 Antibody Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CD55 Antibody Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CD55 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CD55 Antibody Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CD55 Antibody Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CD55 Antibody Players in 2022
Table 12. World CD55 Antibody Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CD55 Antibody Company Evaluation Quadrant
Table 14. Head Office of Key CD55 Antibody Player
Table 15. CD55 Antibody Market: Company Product Type Footprint
Table 16. CD55 Antibody Market: Company Product Application Footprint
Table 17. CD55 Antibody Mergers & Acquisitions Activity
Table 18. United States VS China CD55 Antibody Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CD55 Antibody Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CD55 Antibody Companies, Headquarters (States, Country)
Table 21. United States Based Companies CD55 Antibody Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CD55 Antibody Revenue Market Share (2018-2023)
Table 23. China Based CD55 Antibody Companies, Headquarters (Province, Country)
Table 24. China Based Companies CD55 Antibody Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CD55 Antibody Revenue Market Share (2018-2023)
Table 26. Rest of World Based CD55 Antibody Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CD55 Antibody Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CD55 Antibody Revenue Market Share (2018-2023)
Table 29. World CD55 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CD55 Antibody Market Size by Type (2018-2023) & (USD Million)
Table 31. World CD55 Antibody Market Size by Type (2024-2029) & (USD Million)
Table 32. World CD55 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CD55 Antibody Market Size by Application (2018-2023) & (USD Million)
Table 34. World CD55 Antibody Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck CD55 Antibody Product and Services
Table 38. Merck CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific CD55 Antibody Product and Services
Table 44. Thermo Fisher Scientific CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Proteintech Group Basic Information, Area Served and Competitors
Table 48. Proteintech Group Major Business
Table 49. Proteintech Group CD55 Antibody Product and Services
Table 50. Proteintech Group CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Proteintech Group Recent Developments/Updates
Table 52. Proteintech Group Competitive Strengths & Weaknesses
Table 53. Aviva Systems Biology Basic Information, Area Served and Competitors
Table 54. Aviva Systems Biology Major Business
Table 55. Aviva Systems Biology CD55 Antibody Product and Services
Table 56. Aviva Systems Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Aviva Systems Biology Recent Developments/Updates
Table 58. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 59. LifeSpan BioSciences Basic Information, Area Served and Competitors
Table 60. LifeSpan BioSciences Major Business
Table 61. LifeSpan BioSciences CD55 Antibody Product and Services
Table 62. LifeSpan BioSciences CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. LifeSpan BioSciences Recent Developments/Updates
Table 64. LifeSpan BioSciences Competitive Strengths & Weaknesses
Table 65. RayBiotech Basic Information, Area Served and Competitors
Table 66. RayBiotech Major Business
Table 67. RayBiotech CD55 Antibody Product and Services
Table 68. RayBiotech CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. RayBiotech Recent Developments/Updates
Table 70. RayBiotech Competitive Strengths & Weaknesses
Table 71. Leading Biology Basic Information, Area Served and Competitors
Table 72. Leading Biology Major Business
Table 73. Leading Biology CD55 Antibody Product and Services
Table 74. Leading Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Leading Biology Recent Developments/Updates
Table 76. Leading Biology Competitive Strengths & Weaknesses
Table 77. ProSci Basic Information, Area Served and Competitors
Table 78. ProSci Major Business
Table 79. ProSci CD55 Antibody Product and Services
Table 80. ProSci CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ProSci Recent Developments/Updates
Table 82. ProSci Competitive Strengths & Weaknesses
Table 83. Bethyl Laboratories Basic Information, Area Served and Competitors
Table 84. Bethyl Laboratories Major Business
Table 85. Bethyl Laboratories CD55 Antibody Product and Services
Table 86. Bethyl Laboratories CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bethyl Laboratories Recent Developments/Updates
Table 88. Bethyl Laboratories Competitive Strengths & Weaknesses
Table 89. OriGene Technologies Basic Information, Area Served and Competitors
Table 90. OriGene Technologies Major Business
Table 91. OriGene Technologies CD55 Antibody Product and Services
Table 92. OriGene Technologies CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. OriGene Technologies Recent Developments/Updates
Table 94. OriGene Technologies Competitive Strengths & Weaknesses
Table 95. Novus Biologicals Basic Information, Area Served and Competitors
Table 96. Novus Biologicals Major Business
Table 97. Novus Biologicals CD55 Antibody Product and Services
Table 98. Novus Biologicals CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Novus Biologicals Recent Developments/Updates
Table 100. Novus Biologicals Competitive Strengths & Weaknesses
Table 101. Cell Signaling Technology Basic Information, Area Served and Competitors
Table 102. Cell Signaling Technology Major Business
Table 103. Cell Signaling Technology CD55 Antibody Product and Services
Table 104. Cell Signaling Technology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cell Signaling Technology Recent Developments/Updates
Table 106. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 107. Abcam Basic Information, Area Served and Competitors
Table 108. Abcam Major Business
Table 109. Abcam CD55 Antibody Product and Services
Table 110. Abcam CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Abcam Recent Developments/Updates
Table 112. Abcam Competitive Strengths & Weaknesses
Table 113. GeneTex Basic Information, Area Served and Competitors
Table 114. GeneTex Major Business
Table 115. GeneTex CD55 Antibody Product and Services
Table 116. GeneTex CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. GeneTex Recent Developments/Updates
Table 118. GeneTex Competitive Strengths & Weaknesses
Table 119. United States Biological Basic Information, Area Served and Competitors
Table 120. United States Biological Major Business
Table 121. United States Biological CD55 Antibody Product and Services
Table 122. United States Biological CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. United States Biological Recent Developments/Updates
Table 124. United States Biological Competitive Strengths & Weaknesses
Table 125. St John's Laboratory Basic Information, Area Served and Competitors
Table 126. St John's Laboratory Major Business
Table 127. St John's Laboratory CD55 Antibody Product and Services
Table 128. St John's Laboratory CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. St John's Laboratory Recent Developments/Updates
Table 130. St John's Laboratory Competitive Strengths & Weaknesses
Table 131. Creative Diagnostics Basic Information, Area Served and Competitors
Table 132. Creative Diagnostics Major Business
Table 133. Creative Diagnostics CD55 Antibody Product and Services
Table 134. Creative Diagnostics CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Creative Diagnostics Recent Developments/Updates
Table 136. Creative Diagnostics Competitive Strengths & Weaknesses
Table 137. Biobyt Basic Information, Area Served and Competitors
Table 138. Biobyt Major Business
Table 139. Biobyt CD55 Antibody Product and Services
Table 140. Biobyt CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Biobyt Recent Developments/Updates
Table 142. Jingjie PTM BioLab Basic Information, Area Served and Competitors
Table 143. Jingjie PTM BioLab Major Business
Table 144. Jingjie PTM BioLab CD55 Antibody Product and Services
Table 145. Jingjie PTM BioLab CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of CD55 Antibody Upstream (Raw Materials)
Table 147. CD55 Antibody Typical Customers
List of Figure
Figure 1. CD55 Antibody Picture
Figure 2. World CD55 Antibody Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD55 Antibody Total Market Size (2018-2029) & (USD Million)
Figure 4. World CD55 Antibody Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CD55 Antibody Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 13. CD55 Antibody Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 16. World CD55 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 18. China CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 23. India CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CD55 Antibody by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CD55 Antibody Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CD55 Antibody Markets in 2022
Figure 27. United States VS China: CD55 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD55 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CD55 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CD55 Antibody Market Size Market Share by Type in 2022
Figure 31. Monoclonal
Figure 32. Polyclonal
Figure 33. World CD55 Antibody Market Size Market Share by Type (2018-2029)
Figure 34. World CD55 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CD55 Antibody Market Size Market Share by Application in 2022
Figure 36. Immunochemistry (IHC)
Figure 37. Immunofluorescence (IF)
Figure 38. Immunoprecipitation (IP)
Figure 39. Western Blot (WB)
Figure 40. ELISA
Figure 41. Others
Figure 42. CD55 Antibody Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World CD55 Antibody Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CD55 Antibody Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CD55 Antibody Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CD55 Antibody Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CD55 Antibody Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CD55 Antibody Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CD55 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CD55 Antibody Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CD55 Antibody Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CD55 Antibody Players in 2022
Table 12. World CD55 Antibody Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CD55 Antibody Company Evaluation Quadrant
Table 14. Head Office of Key CD55 Antibody Player
Table 15. CD55 Antibody Market: Company Product Type Footprint
Table 16. CD55 Antibody Market: Company Product Application Footprint
Table 17. CD55 Antibody Mergers & Acquisitions Activity
Table 18. United States VS China CD55 Antibody Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CD55 Antibody Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CD55 Antibody Companies, Headquarters (States, Country)
Table 21. United States Based Companies CD55 Antibody Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CD55 Antibody Revenue Market Share (2018-2023)
Table 23. China Based CD55 Antibody Companies, Headquarters (Province, Country)
Table 24. China Based Companies CD55 Antibody Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CD55 Antibody Revenue Market Share (2018-2023)
Table 26. Rest of World Based CD55 Antibody Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CD55 Antibody Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CD55 Antibody Revenue Market Share (2018-2023)
Table 29. World CD55 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CD55 Antibody Market Size by Type (2018-2023) & (USD Million)
Table 31. World CD55 Antibody Market Size by Type (2024-2029) & (USD Million)
Table 32. World CD55 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CD55 Antibody Market Size by Application (2018-2023) & (USD Million)
Table 34. World CD55 Antibody Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck CD55 Antibody Product and Services
Table 38. Merck CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific CD55 Antibody Product and Services
Table 44. Thermo Fisher Scientific CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Proteintech Group Basic Information, Area Served and Competitors
Table 48. Proteintech Group Major Business
Table 49. Proteintech Group CD55 Antibody Product and Services
Table 50. Proteintech Group CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Proteintech Group Recent Developments/Updates
Table 52. Proteintech Group Competitive Strengths & Weaknesses
Table 53. Aviva Systems Biology Basic Information, Area Served and Competitors
Table 54. Aviva Systems Biology Major Business
Table 55. Aviva Systems Biology CD55 Antibody Product and Services
Table 56. Aviva Systems Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Aviva Systems Biology Recent Developments/Updates
Table 58. Aviva Systems Biology Competitive Strengths & Weaknesses
Table 59. LifeSpan BioSciences Basic Information, Area Served and Competitors
Table 60. LifeSpan BioSciences Major Business
Table 61. LifeSpan BioSciences CD55 Antibody Product and Services
Table 62. LifeSpan BioSciences CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. LifeSpan BioSciences Recent Developments/Updates
Table 64. LifeSpan BioSciences Competitive Strengths & Weaknesses
Table 65. RayBiotech Basic Information, Area Served and Competitors
Table 66. RayBiotech Major Business
Table 67. RayBiotech CD55 Antibody Product and Services
Table 68. RayBiotech CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. RayBiotech Recent Developments/Updates
Table 70. RayBiotech Competitive Strengths & Weaknesses
Table 71. Leading Biology Basic Information, Area Served and Competitors
Table 72. Leading Biology Major Business
Table 73. Leading Biology CD55 Antibody Product and Services
Table 74. Leading Biology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Leading Biology Recent Developments/Updates
Table 76. Leading Biology Competitive Strengths & Weaknesses
Table 77. ProSci Basic Information, Area Served and Competitors
Table 78. ProSci Major Business
Table 79. ProSci CD55 Antibody Product and Services
Table 80. ProSci CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ProSci Recent Developments/Updates
Table 82. ProSci Competitive Strengths & Weaknesses
Table 83. Bethyl Laboratories Basic Information, Area Served and Competitors
Table 84. Bethyl Laboratories Major Business
Table 85. Bethyl Laboratories CD55 Antibody Product and Services
Table 86. Bethyl Laboratories CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bethyl Laboratories Recent Developments/Updates
Table 88. Bethyl Laboratories Competitive Strengths & Weaknesses
Table 89. OriGene Technologies Basic Information, Area Served and Competitors
Table 90. OriGene Technologies Major Business
Table 91. OriGene Technologies CD55 Antibody Product and Services
Table 92. OriGene Technologies CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. OriGene Technologies Recent Developments/Updates
Table 94. OriGene Technologies Competitive Strengths & Weaknesses
Table 95. Novus Biologicals Basic Information, Area Served and Competitors
Table 96. Novus Biologicals Major Business
Table 97. Novus Biologicals CD55 Antibody Product and Services
Table 98. Novus Biologicals CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Novus Biologicals Recent Developments/Updates
Table 100. Novus Biologicals Competitive Strengths & Weaknesses
Table 101. Cell Signaling Technology Basic Information, Area Served and Competitors
Table 102. Cell Signaling Technology Major Business
Table 103. Cell Signaling Technology CD55 Antibody Product and Services
Table 104. Cell Signaling Technology CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cell Signaling Technology Recent Developments/Updates
Table 106. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 107. Abcam Basic Information, Area Served and Competitors
Table 108. Abcam Major Business
Table 109. Abcam CD55 Antibody Product and Services
Table 110. Abcam CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Abcam Recent Developments/Updates
Table 112. Abcam Competitive Strengths & Weaknesses
Table 113. GeneTex Basic Information, Area Served and Competitors
Table 114. GeneTex Major Business
Table 115. GeneTex CD55 Antibody Product and Services
Table 116. GeneTex CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. GeneTex Recent Developments/Updates
Table 118. GeneTex Competitive Strengths & Weaknesses
Table 119. United States Biological Basic Information, Area Served and Competitors
Table 120. United States Biological Major Business
Table 121. United States Biological CD55 Antibody Product and Services
Table 122. United States Biological CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. United States Biological Recent Developments/Updates
Table 124. United States Biological Competitive Strengths & Weaknesses
Table 125. St John's Laboratory Basic Information, Area Served and Competitors
Table 126. St John's Laboratory Major Business
Table 127. St John's Laboratory CD55 Antibody Product and Services
Table 128. St John's Laboratory CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. St John's Laboratory Recent Developments/Updates
Table 130. St John's Laboratory Competitive Strengths & Weaknesses
Table 131. Creative Diagnostics Basic Information, Area Served and Competitors
Table 132. Creative Diagnostics Major Business
Table 133. Creative Diagnostics CD55 Antibody Product and Services
Table 134. Creative Diagnostics CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Creative Diagnostics Recent Developments/Updates
Table 136. Creative Diagnostics Competitive Strengths & Weaknesses
Table 137. Biobyt Basic Information, Area Served and Competitors
Table 138. Biobyt Major Business
Table 139. Biobyt CD55 Antibody Product and Services
Table 140. Biobyt CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Biobyt Recent Developments/Updates
Table 142. Jingjie PTM BioLab Basic Information, Area Served and Competitors
Table 143. Jingjie PTM BioLab Major Business
Table 144. Jingjie PTM BioLab CD55 Antibody Product and Services
Table 145. Jingjie PTM BioLab CD55 Antibody Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of CD55 Antibody Upstream (Raw Materials)
Table 147. CD55 Antibody Typical Customers
List of Figure
Figure 1. CD55 Antibody Picture
Figure 2. World CD55 Antibody Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD55 Antibody Total Market Size (2018-2029) & (USD Million)
Figure 4. World CD55 Antibody Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CD55 Antibody Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CD55 Antibody Revenue (2018-2029) & (USD Million)
Figure 13. CD55 Antibody Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 16. World CD55 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 18. China CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 23. India CD55 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CD55 Antibody by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CD55 Antibody Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CD55 Antibody Markets in 2022
Figure 27. United States VS China: CD55 Antibody Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD55 Antibody Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CD55 Antibody Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CD55 Antibody Market Size Market Share by Type in 2022
Figure 31. Monoclonal
Figure 32. Polyclonal
Figure 33. World CD55 Antibody Market Size Market Share by Type (2018-2029)
Figure 34. World CD55 Antibody Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CD55 Antibody Market Size Market Share by Application in 2022
Figure 36. Immunochemistry (IHC)
Figure 37. Immunofluorescence (IF)
Figure 38. Immunoprecipitation (IP)
Figure 39. Western Blot (WB)
Figure 40. ELISA
Figure 41. Others
Figure 42. CD55 Antibody Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
